Financials
Financial year 2024
PHARMACIE DELEM from Anderlecht, company number BE0436965303, closed financial year 2024 with a result of € 3,158 after tax. For that financial year PHARMACIE DELEM recorded a gross margin of € 193,372 and equity of € 364,971. Compared with financial year 2023, the result moved from € -903 to € 3,158. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.
€ 364,971
▲ 1% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 3,158
▲ still € 903 loss in 2023
Profit after tax over the fiscal year.
€ 127,959
▼ 11% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 345,814.
People and assets in 2024
2.5
Average over the fiscal year, from the social balance sheet.
€ 155,614
▲ 19% vs 2023
€ 62,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 694
▼ 91% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 54,130
▼ 34% vs 2023
€ 26,046 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 155,895
▲ 4% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 69,359
▲ 9% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 158,779 | € 198,186 | € 169,677 | € 193,372 | ▲ 14% |
| Profit after taxes | € 51,338 | € 51,260 | € -903 | € 3,158 | ▲ € 4,061 |
| Equity | € 311,457 | € 362,717 | € 361,813 | € 364,971 | ▲ 1% |
| Total debts | € 268,810 | € 349,693 | € 296,632 | € 279,384 | ▼ 6% |
| Cash | € 112,592 | € 169,687 | € 144,568 | € 127,959 | ▼ 11% |
| Land & buildings | € 58,800 | € 57,033 | € 55,266 | € 53,499 | ▼ 3% |
| Retained profit | € 292,300 | € 343,560 | € 342,656 | € 345,814 | ▲ 1% |
| Bank debt | € 99,294 | € 128,188 | € 82,055 | € 54,130 | ▼ 34% |
| Balance sheet total | € 580,267 | € 712,410 | € 658,445 | € 644,355 | ▼ 2% |
| Employees (FTE) | 2.6 | 3 | 2.5 | 2.5 |
Key figures of PHARMACIE DELEM, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to PHARMACIE DELEM?
What happened at PHARMACIE DELEM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 3,158. filed late Source: NBB ↗
- New establishment in Anderlecht. KBO
- Start of the company according to the CBE. KBO
In short
From € 51,338 profit in 2021 to € 3,158 profit in 2024.
Paid € 33,647 in corporate taxes since 2021.
Best year ever: 2021, with € 51,338 profit.
On average € 77,300 of value added per employee in 2024.
A new publication or filing at PHARMACIE DELEM? We notify you, reason included.
Follow PHARMACIE DELEMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of MED-PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE DELEMBehind PHARMACIE DELEM is MED-PHARMA SRL SRL. The shares are held by MED-PHARMA (70%).
Directors
According to the 2024 annual accounts
Managing director · represented by HIND RAHALI
Shareholders
70%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Eloystraat 86A
1070 Anderlecht
Eloystraat 86 A
1070 Anderlecht
Active since 28 March 1989
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0436.965.303
- VAT number
- BE 0436.965.303
- Registered office
- Eloystraat 86A, 1070 Anderlecht
- Names & denominations
- PHARMACIE DELEM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 March 1989
- Peppol
- Active · Active since 17 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers